SYNTA PHARMACEUTICALS CORP's ticker is and the CUSIP is 87162T956. A total of 2 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,000 | – | 5,000 | +233.3% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 1,500 | -98.6% | 0.00% | – |
| Q4 2015 | $37,000 | -87.2% | 104,200 | -37.0% | 0.00% | -100.0% |
| Q3 2015 | $288,000 | -12.7% | 165,400 | +11.9% | 0.00% | -20.0% |
| Q2 2015 | $330,000 | +146.3% | 147,800 | +114.5% | 0.01% | +150.0% |
| Q1 2015 | $134,000 | +22.9% | 68,900 | +67.6% | 0.00% | 0.0% |
| Q4 2014 | $109,000 | -78.2% | 41,100 | -75.3% | 0.00% | -75.0% |
| Q3 2014 | $501,000 | +137.4% | 166,500 | +223.3% | 0.01% | +166.7% |
| Q2 2014 | $211,000 | -32.8% | 51,500 | -29.3% | 0.00% | -40.0% |
| Q1 2014 | $314,000 | -59.2% | 72,800 | -50.4% | 0.01% | -58.3% |
| Q4 2013 | $770,000 | +30.5% | 146,900 | +57.1% | 0.01% | +9.1% |
| Q3 2013 | $590,000 | -3.8% | 93,500 | -23.9% | 0.01% | -26.7% |
| Q2 2013 | $613,000 | – | 122,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 146,900 | $770,000 | 0.01% |
| Citadel Advisors | 25,600 | $134,000 | 0.00% |